vs
Side-by-side financial comparison of Sanofi (SNY) and Telix Pharmaceuticals Ltd (TLX). Click either name above to swap in a different company.
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of th...
Telix Pharmaceuticals Ltd is a global clinical-stage biopharmaceutical company specializing in the development and commercialization of targeted radiopharmaceutical products for oncology. Its core portfolio covers diagnostic imaging agents and therapeutic treatments for prostate, renal, and neuroendocrine cancers, serving markets across North America, Europe, and Asia-Pacific.
